Buprenorphine-naloxone treatment in opioid use disorder and risk of liver enzyme elevation: results from a 12-month observational study.

From the American Journal of Addiction

New study examines whether opioid-dependent patients suffer possible liver toxicity.

Some case series mention possible liver toxicity in opioid-dependent patients under buprenorphine treatment.This 12-month prospective observational follow-up study in opioid-dependent patients under buprenorphine-naloxone treatment assessed outcome and safety issues. Read study.